An article posted in Medical News Today called, "Type 1 Diabetes Reversed With Stem Cells From Cord Blood", discussed new research being done at the University of Illinois at Chicago, regarding cordblood stem cells and patients with type 1 diabetes.
The research suggests that stem cells from cord blood have helped "re-educate" the T cells of people with type 1 diabetes so that their pancreas started producing insulin again, thereby reducing the amount of insulin needed to be injected into the patient.
The "Stem Cell Educator Therapy" program, is a procedure whereby the diabetic patient’s blood is circulated through a closed-loop system that separates T cells from the whole blood and co-cultures them with cord blood stem cells from healthy donors for two to three hours before returning the “re-educated T-cells” to the patient’s circulation.
This program led by Dr. Yong Zhao, a speaker at the upcoming World Cord Blood Congress event, taking place in Boston September 2012, has proven successful in improving autoimmune control in these patients with type 1 diabetes.
To see the original article click here.
To learn more about the World Cord Blood Congress, click http://www.terrapinn.com/2012/world-cord-blood-congress/?pk_campaign=Terr-Listing&pk_kwd=life+sciencehere.here.